Adenosinergic Mechanisms of Intrauterine Growth Retardation
子宫内生长迟缓的腺苷能机制
基本信息
- 批准号:7938832
- 负责人:
- 金额:$ 41.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdenosineAdenosine A1 ReceptorAdultAdverse effectsAffectAir PollutionAmericanBody CompositionBody fatCaffeineCardiacCardiovascular DiseasesCoffeeCongenital Heart DefectsConsumptionDevelopmentDiabetes MellitusDiseaseDoseElementsEmbryoEmbryonic DevelopmentEnvironmental Risk FactorEpigenetic ProcessEtiologyFetal DevelopmentFetal Growth RetardationFoundationsGene ExpressionGenomicsGoalsGrowthHeartHypoxiaInfantLong-Term EffectsMediatingMetabolicMetabolic syndromeModificationMusNutrientObesityOrganogenesisOxygenPatternPhysiologyPlayPopulationPredispositionPregnancyPregnant WomenProteinsPublic HealthRisk FactorsRoleSignal TransductionSiteSmokingTestingTissuesTransgenic MiceVentricularWomanadverse outcomebasecardiogenesiscostfetal programminghealth economicshigh riskhypoxia inducible factor 1in uteroinsightlifetime risknovel strategiesoffspringprenatalpreventprotective effectstressoryoung adult
项目摘要
Compelling evidence suggests that alteration of normal prenatal development influences one’s lifetime risks for obesity and cardiovascular disorders, which are components of the metabolic syndrome. Reflecting the public health importance of elucidating risk factors for obesity and cardiovascular disease, the metabolic syndrome affects nearly 50 million Americans. Thus, efforts aimed at elucidating the risk factors for adult disease, including those that contribute to a small element of causation, are of major public health and economic importance. The goals of this proposal are to identify the mechanisms by which adenosine acts to protect the embryo in utero and how altered embryonic adenosine action leads to long-term adverse effects in adulthood.
令人信服的证据表明,正常产前发育的改变会影响一个人一生中肥胖和心血管疾病的风险,这是代谢综合征的组成部分。代谢综合征影响了近5000万美国人,这反映了阐明肥胖和心血管疾病的危险因素对公共卫生的重要性。因此,旨在阐明成人疾病风险因素的努力,包括那些促成一小部分因果关系的因素,具有重大的公共卫生和经济意义。本研究的目的是确定腺苷在子宫内保护胚胎的机制,以及胚胎腺苷作用的改变如何导致成年期的长期不良影响。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development.
- DOI:10.1186/1471-213x-11-37
- 发表时间:2011-06-13
- 期刊:
- 影响因子:0
- 作者:Poulsen RR;McClaskey CM;Rivkees SA;Wendler CC
- 通讯作者:Wendler CC
Identification of the heart as the critical site of adenosine mediated embryo protection.
确定心脏是腺苷介导的胚胎保护的关键部位。
- DOI:10.1186/1471-213x-10-57
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Wendler,ChristopherC;Poulsen,RyanR;Ghatpande,Satish;Greene,RobertW;Rivkees,ScottA
- 通讯作者:Rivkees,ScottA
Embryonic caffeine exposure acts via A1 adenosine receptors to alter adult cardiac function and DNA methylation in mice.
- DOI:10.1371/journal.pone.0087547
- 发表时间:2014
- 期刊:
- 影响因子:3.7
- 作者:Buscariollo DL;Fang X;Greenwood V;Xue H;Rivkees SA;Wendler CC
- 通讯作者:Wendler CC
Regulation of cardiovascular development by adenosine and adenosine-mediated embryo protection.
- DOI:10.1161/atvbaha.111.226811
- 发表时间:2012-04
- 期刊:
- 影响因子:0
- 作者:Rivkees SA;Wendler CC
- 通讯作者:Wendler CC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT A. RIVKEES其他文献
SCOTT A. RIVKEES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT A. RIVKEES', 18)}}的其他基金
Prevention of White Matter Injury in Premature Infants
早产儿脑白质损伤的预防
- 批准号:
10028283 - 财政年份:2020
- 资助金额:
$ 41.02万 - 项目类别:
Prevention of White Matter Injury in Premature Infants
早产儿脑白质损伤的预防
- 批准号:
10164837 - 财政年份:2020
- 资助金额:
$ 41.02万 - 项目类别:
Development of a Novel Therapeutic for Hyperthyroidism
甲状腺功能亢进症新疗法的开发
- 批准号:
9908579 - 财政年份:2019
- 资助金额:
$ 41.02万 - 项目类别:
Graves' Disease Therapy Risks to Mother and Fetus
格雷夫斯病治疗对母亲和胎儿的风险
- 批准号:
8536927 - 财政年份:2010
- 资助金额:
$ 41.02万 - 项目类别:
Graves' Disease Therapy Risks to Mother and Fetus
格雷夫斯病治疗对母亲和胎儿的风险
- 批准号:
7989763 - 财政年份:2010
- 资助金额:
$ 41.02万 - 项目类别:
Radioactive Iodide Therapy of Pediatric Graves' Disease
放射性碘化物治疗小儿格雷夫斯病
- 批准号:
8580884 - 财政年份:2010
- 资助金额:
$ 41.02万 - 项目类别:
Graves' Disease Therapy Risks to Mother and Fetus
格雷夫斯病治疗对母亲和胎儿的风险
- 批准号:
8146045 - 财政年份:2010
- 资助金额:
$ 41.02万 - 项目类别:
相似国自然基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
- 批准号:82074359
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
- 批准号:81570244
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
- 批准号:81171113
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
- 批准号:
BB/W016974/1 - 财政年份:2023
- 资助金额:
$ 41.02万 - 项目类别:
Research Grant
Allostery-driven G protein selectivity in the adenosine A1 receptor
腺苷 A1 受体中变构驱动的 G 蛋白选择性
- 批准号:
BB/W014831/1 - 财政年份:2022
- 资助金额:
$ 41.02万 - 项目类别:
Research Grant
Investigation of the relationship among Adenosine A1 receptor activity and HRV
腺苷A1受体活性与HRV关系的研究
- 批准号:
20K09341 - 财政年份:2020
- 资助金额:
$ 41.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Changes in adenosine A1 receptor-mediated regulation of hippocampal area CA2 following chronic high-dose caffeine treatment during adolescence in rats
大鼠青春期长期大剂量咖啡因治疗后腺苷 A1 受体介导的海马区 CA2 调节的变化
- 批准号:
BB/P008143/2 - 财政年份:2019
- 资助金额:
$ 41.02万 - 项目类别:
Research Grant
Adenosine A1 receptor modulation: Structure, dynamics & novel pharmacological interventions
腺苷 A1 受体调节:结构、动力学
- 批准号:
nhmrc : GNT1145420 - 财政年份:2018
- 资助金额:
$ 41.02万 - 项目类别:
Project Grants
Adenosine A1 receptor modulation: Structure, dynamics & novel pharmacological interventions
腺苷 A1 受体调节:结构、动力学
- 批准号:
nhmrc : 1145420 - 财政年份:2018
- 资助金额:
$ 41.02万 - 项目类别:
Project Grants
Changes in adenosine A1 receptor-mediated regulation of hippocampal area CA2 following chronic high-dose caffeine treatment during adolescence in rats
大鼠青春期长期大剂量咖啡因治疗后腺苷 A1 受体介导的海马区 CA2 调节的变化
- 批准号:
BB/P008143/1 - 财政年份:2017
- 资助金额:
$ 41.02万 - 项目类别:
Research Grant
Understanding mechanisms of allostery and biased agonism at the adenosine A1 receptor
了解腺苷 A1 受体的变构和偏向激动机制
- 批准号:
nhmrc : 1084246 - 财政年份:2015
- 资助金额:
$ 41.02万 - 项目类别:
Project Grants
Analgesic actions of adenosine A1 receptor along axonal tracts in chronic pain
腺苷 A1 受体沿轴突束对慢性疼痛的镇痛作用
- 批准号:
9101984 - 财政年份:2013
- 资助金额:
$ 41.02万 - 项目类别:
Analgesic actions of adenosine A1 receptor along axonal tracts in chronic pain
腺苷 A1 受体沿轴突束对慢性疼痛的镇痛作用
- 批准号:
9294975 - 财政年份:2013
- 资助金额:
$ 41.02万 - 项目类别: